Cargando…
Commercial hybrid closed-loop systems available for a patient with type 1 diabetes in 2022
Technological advances offer the opportunity to improve glycemic control and reduce the risk of complications and burden of type 1 diabetes while improving patient quality of life. Closed-loop insulin delivery systems take the technology to a larger scale by integrating CGM systems with an insulin p...
Autores principales: | Seget, Sebastian, Tekielak, Anna, Rusak, Ewa, Jarosz-Chobot, Przemysława |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226452/ https://www.ncbi.nlm.nih.gov/pubmed/37218723 http://dx.doi.org/10.5114/pedm.2023.126359 |
Ejemplares similares
-
Thyroid diseases – ally or enemy of type 1 diabetes in children and adolescents?
por: Ogarek, Natalia, et al.
Publicado: (2021) -
Glucose management indicator – potential factors affecting differences in comparison with HbA1c and clinical significance of this phenomenon
por: Wybrańczyk, Łukasz, et al.
Publicado: (2023) -
Atherosclerosis: risk assessment and the role of aiming for optimal glycaemic control in young patients with type 1 diabetes
por: Kolasa, Martyna, et al.
Publicado: (2022) -
Prospective Open-Label, Single-Arm, Single-Center Follow-Up Study of the Application of the Advanced Hybrid Closed Loop System in Well-Controlled Children and Adolescents with Type 1 Diabetes
por: Seget, Sebastian, et al.
Publicado: (2022) -
Can the AHCL System Be Used in T1D Patients with Borderline TDDI? A Case Report
por: Tekielak, Anna, et al.
Publicado: (2021)